Table 4

PK parameters of barasertib and barasertib-hQPA following a 7-day infusion of barasertib 1200 mg in part B

PK parameterGeometric mean (CV, %) [n]
Barasertib (n = 32)Barasertib-hQPA (n = 32)
Css, ng/mL 87.4 (46.2) [13] 245.2 (22.7) [15] 
AUC, ng/h/mL NC 40 930 (20.7) [12] 
AUC0–192h, ng/h/mL 14 030 (46.0) [13]* 39 300 (22.3) [15] 
CL, L/h NC 29.3 (22.8) [12] 
Vss, L NC 614.2 (42.7) [12] 
Vz, L NC 3278 (44.1) [12] 
t1/2, h NC 77.5 (34.6) [12] 
PK parameterGeometric mean (CV, %) [n]
Barasertib (n = 32)Barasertib-hQPA (n = 32)
Css, ng/mL 87.4 (46.2) [13] 245.2 (22.7) [15] 
AUC, ng/h/mL NC 40 930 (20.7) [12] 
AUC0–192h, ng/h/mL 14 030 (46.0) [13]* 39 300 (22.3) [15] 
CL, L/h NC 29.3 (22.8) [12] 
Vss, L NC 614.2 (42.7) [12] 
Vz, L NC 3278 (44.1) [12] 
t1/2, h NC 77.5 (34.6) [12] 

NC indicates not calculable.

*

AUC0-192h for barasertib.

Close Modal

or Create an Account

Close Modal
Close Modal